Methane

Methane

SCHEMBL6506917

C.COC(=O)c1cc(S(=O)(=O)N(CCc2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)Cc2ccc(C(F)(F)F)cc2)ccc1C

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 3/20 0.48
CA12 O43570 3/20 0.44
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA4 P22748 3/20 0.44
CA9 Q16790 3/20 0.44
MMP13 P45452 2/20 0.44
ADAMTS4 O75173 1/20 0.44
TAS2R14 Q9NYV8 1/20 0.43
PTPN1 P18031 2/20 0.41
MAOB P27338 1/20 0.41
MMP9 P14780 2/20 0.41
ADAM17 P78536 1/20 0.41
BCL2L1 Q07817 1/20 0.41
MCL1 Q07820 1/20 0.41
MMP2 P08253 1/20 0.40
MAPT P10636 1/20 0.40
AR P10275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905982 0.99 BMP1 (0.49) BMP1CA12CA1CA2CA4
SCHEMBL4894471 0.91 CA12 (0.48) BMP1CA12CA1CA2CA4
SCHEMBL4900038 0.90 TAS2R14 (0.46) BMP1CA12CA1CA2CA9
SCHEMBL4908413 0.89 CNR2 (0.48) BMP1CA12CA1CA2CA4
SCHEMBL4895626 0.89 TAS2R14 (0.56) BMP1CA12CA1CA2CA4
SCHEMBL4902732 0.88 KMT2A (0.48) BMP1CA12CA1CA2CA4
SCHEMBL4904145 0.85 MMP2 (0.45) BMP1CA12CA1CA2CA4
SCHEMBL4905637 0.85 TAS2R14 (0.44) BMP1CA12CA1CA2CA4
SCHEMBL4904285 0.84 TP53 (0.45) BMP1CA12CA1CA2CA4
SCHEMBL4899749 0.82 ERBB2 (0.50) MMP13ADAMTS4MAOBMMP9ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD BMP1 3689/4885CA12 4883/4885CA1 4881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.